The report provides a detailed analysis essential for establishing a Cefotetan production plant. It encompasses all critical aspects necessary for Cefotetan production, including the cost of Cefotetan production, Cefotetan plant cost, Cefotetan production costs, and the overall Cefotetan production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Cefotetan production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Cefotetan is an antibiotic that belongs to the cephalosporin family, which is used to treat and prevent bacterial infections. It works by stopping bacteria from forming their protective cell walls, which kills them and stops the infection from spreading. It is utilised to treat infections of the lungs, urinary tract, skin, bones, joints, and abdomen. It is also very effective for treating gynaecological infections like pelvic inflammatory disease and endometritis. It is given before surgeries involving the stomach, intestines, or reproductive organs to prevent infection after the procedure.
It can fight both aerobic and anaerobic bacteria, and is useful in mixed infections and serious cases like sepsis. It is given as an injection in hospitals or clinics, and has a long duration of action, which makes it convenient for dosing every 12 or 24 hours.
The market for Cefotetan is fuelled by the growing global cases of serious bacterial infections. Its utilisation in pneumonia, UTIs, intra-abdominal sepsis, and skin infections contributes to its market growth. The rise in surgical cases requires a need for better antibiotics to fight postoperative infections, which fuels the demand. The antimicrobial resistance trends push demand for reliable second-generation cephalosporins effective against gram-negative and anaerobic pathogens, which boosts their demand in expanding hospital networks and healthcare access.
The generic availability since patent expiry has lowered costs, enabling penetration into emerging markets, fuels its demand. The industrial Cefotetan procurement is affected by API supply shortages from regulatory compliance issues, raw material instability, and demand spikes during infection surges.
Raw Material for Cefotetan Production
According to the Cefotetan production plant project report, the key raw materials used in the production of Cefotetan include 7β-(substituted-acetamido)-7α-methoxycephalosporin core and (1-methyl-1H-tetrazol-5-yl)thioacetic acid.
Production Process of Cefotetan
The extensive Cefotetan production cost report consists of the following major industrial production process:
- From 7β-(substituted-acetamido)-7α-methoxycephalosporin Core: The production of Cefotetan starts with a cephalosporin core like 7-aminocephalosporanic acid derivative and attaching a side chain from (1-methyl-1H-tetrazol-5-yl)thioacetic acid. This is done using coupling agents at low temperatures to build the beta-lactam structure. The protective groups are stripped off with acids like trifluoroacetic acid, and the product is purified through chromatography or crystallisation to get Cefotetan.
Cefotetan has the molecular formula of C17H17N7O8S4 and has a molecular weight of 575.62 g/mol. It is a semisynthetic cephamycin antibiotic that appears as a white to pale yellow crystalline powder. It has very high water solubility. It exhibits zwitterionic character with pKa values around 2.3 (carboxylic acid), 3.5 (dithioacetic acid), and ~7.5 (amine). It has a physiological charge of -1.5 and a logP value of -3.2, indicating hydrophilicity. It has a polar surface area of 219.9 Ų, and 4 hydrogen bond donors and 11 acceptors. Its Reconstituted solutions are colourless to yellow with a pH of 4.5-6.5, containing 80 mg of sodium per gram of activity, and remain stable for 24 hours at room temperature or 96 hours refrigerated.
